Preclinical Studies of Gli1 Inhibition in Ewing Family Tumors
|
Children’s Hospital Los Angeles / William May |
Innovation Grants |
2008 |
California |
Preclinical Testing of Candidate Therapeutics in a Pediatric Spinal Cord High-grade Glioma Model |
Stanford University / Michelle Monje, MD/PhD |
Innovation Grants |
2016 |
California |
Predicting and Overcoming Resistance to Immunotherapy in Pediatric High-Grade Glioma |
Ann & Robert H. Lurie Children’s Hospital of Chicago / Oren Becher, MD & Robert Wechsler-Reya, PhD |
Innovation Grants |
2019 |
Illinois |
Predicting Outcome and Ameliorating Toxicities of the Immunotherapy of Neuroblastoma |
University of California, San Diego / Alice Yu, MD, PhD |
Innovation Grants |
2011 |
California |
Predicting Outcome for Patients with Metastatic Neuroblastoma by Analysis of Bone Marrow and Blood for a Neuroblastoma Gene Expression Signature |
Children’s Hospital Los Angeles / Robert Seeger |
Innovation Grants |
2010 |
California |
Predictive Modeling of MDS Disease Progression From Inherited Bone Marrow Failure Syndrome Using Novel Branching Process and Next Generation Sequencing to Improve Patient-Specific Survival |
Cleveland Clinic Foundation / Seth Corey, MD & Marek Kimmel, PhD |
Innovation Grants |
2017 |
Ohio |
Rac in p190-BCR-ABL0Induced Leukemia.
|
Cincinnati Children's Hospital Medical Center / Jose Cancelas, MD, PhD |
Innovation Grants |
2007 |
Ohio |
Racial and Ethnic Disparities in Survival of Children with Neuroblastoma |
University of Chicago / Susan Cohn, MD |
Innovation Grants |
2011 |
Illinois |
Reactivating Apoptosis in Refractory Pediatric Cancer by Molecular Inhibition of MCL-1 |
Dana-Farber Cancer Institute / Loren Walensky, MD, PhD |
Innovation Grants |
2013 |
Massachusetts |
Redefining the Cellular Architecture of Diffuse Intrinsic Pontine Glioma through Large-Scale Single-cell RNA-seq Analyses |
Massachusetts General Hospital / Mario Suva, MD/PhD |
Innovation Grants |
2016 |
Massachusetts |